Cy7 NHS Ester: Technical Use Guide for Near-Infrared Labelin
Cy7 NHS Ester: Technical Use Guide for Near-Infrared Labeling
What This Product Solves
Sulfo-Cy7 NHS Ester addresses several persistent challenges in biomolecule labeling workflows. Traditional near-infrared dyes often suffer from poor water solubility and dye-dye aggregation, leading to quenching and compromised signal during labeling of delicate proteins. This product is designed as a sulfonated, hydrophilic, and highly water-soluble near-infrared dye for bioimaging, specifically for covalent labeling of amino groups in proteins and peptides. The added sulfonate groups in Cy7 NHS ester enhance solubility, minimize aggregation, and support robust fluorescent labeling even in the absence of organic co-solvents. This is critical for workflows where protein structure and function must be preserved, such as in live-cell imaging or in vivo tracking of sensitive biomolecules. The excitation (750 nm) and emission (773 nm) maxima fall within the near-infrared window, optimizing detection through biological tissues for non-destructive monitoring of probe distribution.
Protocol Parameters
-
Assay: Protein or peptide labeling
Value with unit: Use 10–20 μM Cy7 NHS ester per mg of protein (workflow recommendation)
Applicability: Optimization of dye-to-protein ratio for efficient conjugation with minimal aggregation
Rationale: Ensures adequate labeling intensity while minimizing dye-induced protein denaturation and background
Source type: Workflow recommendation -
Assay: Solvent compatibility
Value with unit: Soluble in water, DMF, DMSO (product information)
Applicability: Flexible protocol design; enables labeling of delicate proteins without organic co-solvents
Rationale: Hydrophilicity reduces risk of protein denaturation compared to hydrophobic dyes
Source type: Product dossier -
Assay: Storage condition
Value with unit: Store at -20°C, protected from light, up to 24 months (product information)
Applicability: Ensures chemical integrity for reproducible labeling
Rationale: Prevents hydrolysis and photobleaching; solutions should be prepared fresh and used promptly
Source type: Product dossier
Workflow Setup and QC Checklist
To achieve reproducible and high-quality labeling with Cy7 NHS ester, consider the following procedural steps and quality control measures:
- Buffer selection: Use amine-free buffers (e.g., PBS, pH 7.2–8.5) to avoid competitive hydrolysis of the NHS ester. Avoid Tris or glycine buffers during conjugation.
- Protein preparation: Ensure protein is free of primary amine-containing additives and sufficiently concentrated (≥1 mg/mL) for efficient labeling.
- Dye handling: Prepare Cy7 NHS ester stock immediately before use. Protect from ambient light and avoid repeated freeze-thaw cycles.
- Reaction time: Typically, incubate the protein-dye mixture for 30–60 minutes at room temperature in the dark. Monitor for precipitation or turbidity as indicators of overlabeling or aggregation.
- Purification: Remove unreacted dye using size-exclusion chromatography or desalting columns with a cut-off suitable for your protein size.
- Quality control: Assess the degree of labeling spectrophotometrically (using the extinction coefficient, 240,600 M⁻¹cm⁻¹ at 750 nm) and verify protein integrity via SDS-PAGE or activity assays if relevant.
For detailed workflow practices and troubleshooting, the article "Cy7 NHS Ester: Protocols and QC for Near-Infrared Protein Labeling" offers protocol recommendations and cautions for sensitive applications, including the avoidance of organic co-solvents and the importance of accessible amino groups.
Common Failure Modes and Fixes
- Low labeling efficiency: Confirm that the protein lacks buffer additives containing competing amines. Increase the dye-to-protein ratio incrementally, but beware of overlabeling.
- Protein precipitation or loss of activity: If using higher dye concentrations, reduce the amount or perform labeling at lower temperatures. Validate protein stability post-labeling using functional assays.
- High background fluorescence: Incomplete removal of unreacted dye is a frequent cause; repeat purification steps or select a smaller cut-off desalting column.
- Photobleaching: Always handle Cy7 NHS ester and conjugates under subdued light. Store labeled biomolecules at 4°C in the dark and use within days of preparation.
The article "Sulfo-Cy7 NHS Ester (SKU A8109): Practical Solutions for..." details real-world troubleshooting scenarios, specifically addressing labeling specificity and workflow reproducibility for biomedical researchers.
Scope and Limitations
- Target requirements: Cy7 NHS ester is suitable only for biomolecules with accessible primary amines (e.g., lysines, N-termini). Not appropriate for labeling nucleic acids or carbohydrates without amine modification.
- Solution stability: The NHS ester is labile in aqueous solution; do not store working solutions for extended periods. Prepare just prior to labeling.
- Storage and handling: The dry product is stable at -20°C in the dark for up to 24 months, but is sensitive to moisture and light. Transport at room temperature for up to 3 weeks is acceptable, but long-term solution storage is not recommended.
- Imaging compatibility: Optimized for in vitro and in vivo near-infrared fluorescent imaging, but users should verify spectral compatibility with their specific detection instrumentation.
Conclusion
For researchers seeking a robust, water-soluble protein labeling dye for near-infrared applications, Cy7 NHS ester (APExBIO SKU A8109) offers a practical solution for conjugation workflows demanding sensitivity and minimal disruption of protein structure. Its hydrophilic, sulfonated design addresses common pitfalls of dye aggregation and protein denaturation, provided that protocols are optimized for buffer composition, dye-to-protein ratio, and prompt use of freshly prepared solutions. By adhering to best practices outlined above and referencing detailed troubleshooting in related internal articles, researchers can achieve reproducible, high-contrast fluorescent labeling for both in vitro and in vivo imaging workflows.